Chu Chun Weng
Algemeen Directeur bij TWI BIOTECHNOLOGY, INC.
Oorsprong van het eerstegraads netwerk van Chu Chun Weng
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Chu Chun Weng via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
TWI PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CIDC Consultants, Inc.
CIDC Consultants, Inc. Investment ManagersFinance CIDC Consultants, Inc. (CIDC Consultants) is an independent, Taiwan-based venture capital firm which was established in 1988 to offer management consulting, serve as an intermediary for domestic and foreign investment, facilitate investment-related technology cooperation, provide business intelligence and deliver inquiry services for venture capital firms. Located in Taipei, the firm manages funds backed by Taiwanese companies in a range of industries and works with European and American partners to make joint investments. CIDC has a cooperative relationship with Doughty Hanson & Co. and their affiliate, Global Financial Services, helps their investee companies to establish sound financial systems. ? | Investment Managers | President | |
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member | |
DV BIOMED CO., LTD. | Biotechnology | Director/Board Member | |
New York University | College/University | Doctorate Degree | |
National Tsing-Hua University | College/University | Graduate Degree | |
National Taiwan University | College/University | Undergraduate Degree | |
Indiana University | College/University | Graduate Degree | |
KGI Capital Asia Ltd.
KGI Capital Asia Ltd. Investment Banks/BrokersFinance Part of China Development Financial Holding Corp., KGI Capital Asia Ltd. is a brokerage firm. The company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Pun Yuen Lam. | Investment Banks/Brokers | Director/Board Member | |
KGI Securities Co., Ltd.
KGI Securities Co., Ltd. Investment Banks/BrokersFinance KGI Securities Co., Ltd. provides securities broking, underwriting, and proprietary trading services. It also offers investment banking consultancy, warrants issuance, bonds conversion, fixed income trading, and wealth management services. Its products include derivatives, bond and equity options, mutual funds, and structured products. The company was founded on September 14, 1988 and is headquartered in Taipei, Taiwan. | Investment Banks/Brokers | Corporate Officer/Principal | |
StemCyte, Inc.
StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Biotechnology | Chairman | |
National Defense Medical Center | College/University | Undergraduate Degree | |
Sycamore Management Corp.
Sycamore Management Corp. Investment ManagersFinance Sycamore Management Corp. (dba Sycamore Ventures) is an independent asset management firm headquartered in Princeton, New Jersey. The firm was founded in 1995 by Joseph Cho and Peter Gerry. Sycamore Ventures manages investment portfolios for individual and institutional clients. | Investment Managers | Portfolio Manager-Equities | |
University of Iowa | College/University | Graduate Degree | |
MAXIGEN BIOTECH INC. | Biotechnology | President | |
U-Systems, Inc.
U-Systems, Inc. Medical SpecialtiesHealth Technology U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY. | Medical Specialties | Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sycamore Ventures Pte Ltd.
Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures Pte Ltd. (Sycamore Ventures) is a private equity and venture capital subsidiary of Sycamore Management Corp., founded in 1995 by Mr. Kilin To, Mr. Peter Gerry, and the late Mr. John Whitman. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
SCINOPHARM TAIWAN, LTD. | Biotechnology | Chief Operating Officer | |
ACTS Biotech, Inc. | Chairman | ||
ADVANCED LITHIUM ELECTROCHEMISTRY (CAYMAN) CO., LTD. | Chemicals: Specialty | Chief Executive Officer | |
COLAND HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
China Investment & Development Co. Ltd.
China Investment & Development Co. Ltd. Investment ManagersFinance China Investment & Development Co Ltd invests in Taiwan-based companies operating in the field of financial services. It provides financing for early and later stage capital requirements. | Investment Managers | President | |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Medical/Nursing Services | Corporate Officer/Principal | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Georgia | College/University | Doctorate Degree |
Statistieken
Internationaal
Taiwan | 14 |
Verenigde Staten | 14 |
Hongkong | 2 |
China | 2 |
Sectoraal
Health Technology | 11 |
Consumer Services | 9 |
Finance | 7 |
Process Industries | 2 |
Health Services | 2 |
Operationeel
Director/Board Member | 14 |
Independent Dir/Board Member | 5 |
President | 5 |
Corporate Officer/Principal | 4 |
Graduate Degree | 3 |
Sterkste connecties
Insiders | |
---|---|
Li Yan Chang | 11 |
Jonas Wang | 10 |
Yi Chun Wu | 6 |
Yueh Yueh | 3 |
Sen Hsiung Chang | 2 |
Chia Ching Chen | 2 |
Kuang Wei Lu | 2 |
Lien I Ho | 1 |
Pei Lan Chu | 1 |
Emily Lin | 1 |
Pei Chih Chen | 1 |
- Beurs
- Insiders
- Chu Chun Weng
- Bedrijfsconnecties